跳至主要内容
临床试验/NCT01242592
NCT01242592已完成2 期

Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary Tuberculosis: Randomized Placebo Controlled Trial

NMP Medical Research Institute1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2005年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
56
试验地点
1
主要终点
Sputum conversion

研究概览

简要总结

The purpose of the study is to evaluate the effect of homeopathy as an adjuvant to Anti tuberculosis treatment on sputum conversion, hematological, clinical sign and symptoms of relapsed Pulmonary TB.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • relapse pulmonary tuberculosis patients with acid-fast bacilli smear positive by microscopy, using ZiehlNieelsen staining as recommended by WHO, unfit for DOTS -

排除标准

  • pregnancy, clinical sign of any concomitant disease such as diabetes mellitus, acute renal failure or infectious disease including TB/HIV and HIV positive, currently or taken any alternative therapies in past 6 months

研究组 & 干预措施

Homeopathy

Experimental

干预措施: Anti-Tuberculosis Treatment (Drug)

Placebo

Placebo Comparator

干预措施: Anti-Tuberculosis Treatment (Drug)

结局指标

主要结局

Sputum conversion

Sputum AFB status by microscopy will be recorded. Sputum conversion is defined as three consecutive sputum smears negative for AFB.

次要结局

  • Quality of Life

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验